Amid stubbornly high syphilis rates, pandemic-era Atomo is developing a point-of-care assay to detect active cases of the venereal disease. ...
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.